Health
Novel protection pathway makes cells resistant to viral infection – Drug Target Review
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Posted: 28 August 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Researchers have discovered a new cellular protection mechanism which they demonstrated can prevent viruses, including Ebola and coronaviruses like SARS-CoV-2, from infecting cells. According to the collaborators, the new understanding surrounding cellular mechanisms in…
-
General18 hours agoChina was the big disruptor in our region. Now the US is determined to take that title
-
General18 hours agoSpaceX to invest $3 billion in Musk’s xAI startup
-
General22 hours agoAlgal bloom ‘disaster’ prompts royal commission call as impact spreads to mussel farms
-
Noosa News22 hours agoE-bikes shouldn’t be banned. The illegal ones are already illegal